228 related articles for article (PubMed ID: 12569392)
1. Temozolomide induces apoptosis and senescence in glioma cells cultured as multicellular spheroids.
Günther W; Pawlak E; Damasceno R; Arnold H; Terzis AJ
Br J Cancer; 2003 Feb; 88(3):463-9. PubMed ID: 12569392
[TBL] [Abstract][Full Text] [Related]
2. The inhibition of proliferation and migration of glioma spheroids exposed to temozolomide is less than additive if combined with irradiation.
Fehlauer F; Muench M; Richter E; Rades D
Oncol Rep; 2007 Apr; 17(4):941-5. PubMed ID: 17342340
[TBL] [Abstract][Full Text] [Related]
3. Multifaceted resistance of gliomas to temozolomide.
Bocangel DB; Finkelstein S; Schold SC; Bhakat KK; Mitra S; Kokkinakis DM
Clin Cancer Res; 2002 Aug; 8(8):2725-34. PubMed ID: 12171906
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine.
Roos WP; Batista LF; Naumann SC; Wick W; Weller M; Menck CF; Kaina B
Oncogene; 2007 Jan; 26(2):186-97. PubMed ID: 16819506
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of DNA repair for sensitizing resistant glioma cells to temozolomide.
Kanzawa T; Bedwell J; Kondo Y; Kondo S; Germano IM
J Neurosurg; 2003 Dec; 99(6):1047-52. PubMed ID: 14705733
[TBL] [Abstract][Full Text] [Related]
6. [Molecular pharmacology on DNA methylating agent temozolomide].
Hirose Y; Sano H
No Shinkei Geka; 2007 Feb; 35(2):117-29. PubMed ID: 17310751
[No Abstract] [Full Text] [Related]
7. Involvement of the mismatch repair system in temozolomide-induced apoptosis.
D'Atri S; Tentori L; Lacal PM; Graziani G; Pagani E; Benincasa E; Zambruno G; Bonmassar E; Jiricny J
Mol Pharmacol; 1998 Aug; 54(2):334-41. PubMed ID: 9687575
[TBL] [Abstract][Full Text] [Related]
8. The adherens junction-associated protein 1 is a negative transcriptional regulator of MAGEA2, which potentiates temozolomide-induced apoptosis in GBM.
Zeng L; Kang C; Di C; Fee BE; Rivas M; Lin J; Adamson DC
Int J Oncol; 2014 Apr; 44(4):1243-51. PubMed ID: 24481586
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional targeting of adenovirally delivered tumor necrosis factor alpha by temozolomide in experimental glioblastoma.
Yamini B; Yu X; Gillespie GY; Kufe DW; Weichselbaum RR
Cancer Res; 2004 Sep; 64(18):6381-4. PubMed ID: 15374943
[TBL] [Abstract][Full Text] [Related]
10. The allosteric AKT inhibitor MK2206 shows a synergistic interaction with chemotherapy and radiotherapy in glioblastoma spheroid cultures.
Narayan RS; Fedrigo CA; Brands E; Dik R; Stalpers LJ; Baumert BG; Slotman BJ; Westerman BA; Peters GJ; Sminia P
BMC Cancer; 2017 Mar; 17(1):204. PubMed ID: 28320338
[TBL] [Abstract][Full Text] [Related]
11. Effects of photodynamic therapy on glioma spheroids.
Terzis AJ; Dietze A; Bjerkvig R; Arnold H
Br J Neurosurg; 1997 Jun; 11(3):196-205. PubMed ID: 9231006
[TBL] [Abstract][Full Text] [Related]
12. Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398.
Joki T; Heese O; Nikas DC; Bello L; Zhang J; Kraeft SK; Seyfried NT; Abe T; Chen LB; Carroll RS; Black PM
Cancer Res; 2000 Sep; 60(17):4926-31. PubMed ID: 10987308
[TBL] [Abstract][Full Text] [Related]
13. Effects of N-6 essential fatty acids on glioma invasion and growth: experimental studies with glioma spheroids in collagen gels.
Bell HS; Wharton SB; Leaver HA; Whittle IR
J Neurosurg; 1999 Dec; 91(6):989-96. PubMed ID: 10584845
[TBL] [Abstract][Full Text] [Related]
14. O6-methylguanine-DNA methyltransferase, O6-benzylguanine, and resistance to clinical alkylators in pediatric primary brain tumor cell lines.
Bobola MS; Silber JR; Ellenbogen RG; Geyer JR; Blank A; Goff RD
Clin Cancer Res; 2005 Apr; 11(7):2747-55. PubMed ID: 15814657
[TBL] [Abstract][Full Text] [Related]
15. Migration, proliferation, and invasion of human glioma cells following treatment with simvastatin.
Gliemroth J; Zulewski H; Arnold H; Terzis AJ
Neurosurg Rev; 2003 May; 26(2):117-24. PubMed ID: 12962298
[TBL] [Abstract][Full Text] [Related]
16. Delayed repletion of O6-methylguanine-DNA methyltransferase resulting in failure to protect the human glioblastoma cell line SF767 from temozolomide-induced cytotoxicity.
Hirose Y; Kreklau EL; Erickson LC; Berger MS; Pieper RO
J Neurosurg; 2003 Mar; 98(3):591-8. PubMed ID: 12650433
[TBL] [Abstract][Full Text] [Related]
17. Preclinical evaluation of binimetinib (MEK162) delivered via polymeric nanocarriers in combination with radiation and temozolomide in glioma.
Bikhezar F; de Kruijff RM; van der Meer AJGM; Torrelo Villa G; van der Pol SMA; Becerril Aragon G; Gasol Garcia A; Narayan RS; de Vries HE; Slotman BJ; Denkova AG; Sminia P
J Neurooncol; 2020 Jan; 146(2):239-246. PubMed ID: 31875307
[TBL] [Abstract][Full Text] [Related]
18. Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication.
Aghi M; Rabkin S; Martuza RL
J Natl Cancer Inst; 2006 Jan; 98(1):38-50. PubMed ID: 16391370
[TBL] [Abstract][Full Text] [Related]
19. Temozolomide and carmustine cause large-scale heterochromatin reorganization in glioma cells.
Papait R; Magrassi L; Rigamonti D; Cattaneo E
Biochem Biophys Res Commun; 2009 Feb; 379(2):434-9. PubMed ID: 19116135
[TBL] [Abstract][Full Text] [Related]
20. p53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells.
Hirose Y; Berger MS; Pieper RO
Cancer Res; 2001 Mar; 61(5):1957-63. PubMed ID: 11280752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
